Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Chengdu First People's Hospital | OTHER |
| Chengdu PLA General Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether acupuncture is effective for relieving perimenopausal symptoms.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Acupuncture | Experimental | Using basic points combined with additional points. Basic points are fixed, while additional points will be selected from a list of points categorized by syndrome differentiation. |
|
| Climen 21 Tablets | Active Comparator | COMPOSITION 11 white tablets each containing estradiol-17-valerate 2 mg, plus 10 pink tablets each containing estradiol-17-valerate 2 mg and cyproterone acetate 1 mg. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Acupuncture | Other | Acupuncture is a collection of procedures involving penetration of the skin with needles to stimulate certain points on the body. In its classical form it is a characteristic component of traditional Chinese medicine (TCM), a form of alternative medicine, and one of the oldest healing practices in the world. |
| Measure | Description | Time Frame |
|---|---|---|
| Menopause Rating Scale | The scale was developed and validated over the years from a research network of many institutions such as Organon Germany, Infratest Munich, Universities of Muenster and Berlin,the Berlin Center for Epidemiology and Health Research, etc. It is a scale consisted of 11 items, ranging from no symptoms to very severe symptoms. | 12 weeks after randomization |
| Measure | Description | Time Frame |
|---|---|---|
| Menopausal Specific Quality of Life Questionnaire | The Menopausal Specific Quality of Life Questionnaire (MENQOL) is self-administered and consists of a total of 29 items in a Likert-scale format. Each item assesses the impact of one of four domains of menopausal symptoms, as experienced over the last month: vasomotor (items 1-3), psychosocial (items 4-10), physical (items 11-26), and sexual (items 27-29). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ying Li, MD, PhD | Chengdu University of Traditional Chinese Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chengdu University of Traditional Chinese Medicine | Chengdu | Sichuan | 610075 | China | ||
| First affiliated hospital of Chengdu University of TCM |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 24886348 | Derived | Li Y, Zheng H, Zheng Q, Zhao L, Qin E, Wang Y, Zeng Q, Zheng H, Zhao Y, Sun W, Zhang X, Liu Z, Liu B. Use acupuncture to relieve perimenopausal syndrome: study protocol of a randomized controlled trial. Trials. 2014 May 30;15:198. doi: 10.1186/1745-6215-15-198. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D019584 | Hot Flashes |
| ID | Term |
|---|---|
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D015670 | Acupuncture Therapy |
| C103294 | estradiol valerate, cyproterone acetate drug combination |
| ID | Term |
|---|---|
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Climen 21 Tablets | Drug | Climen Tablets are commonly used for menopausal symptoms |
|
|
| asessed 0, 6, 12, 24, 36 weeks after randomization |
| Average hot flash score during 24 hours | 0, 12, 24, 36 weeks after randomization |
| Level of Estradiol in serum | 0, 12, 24 weeks after randomization |
| Level of follicle stimulating hormone in serum | 0, 12, 24 weeks after randomization |
| Level of luteinizing hormone in serum | 0, 12, 24 weeks after randomization |
| Chengdu |
| Sichuan |
| 610075 |
| China |